Online Program Home
My Program

Sessions Were Renumbered as of May 19.

CC-W = McCormick Place Convention Center, West Building,   CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago,   UC= Conference Chicago at University Center
* = applied session       ! = JSM meeting theme

Activity Details

137 * ! Mon, 8/1/2016, 8:30 AM - 10:20 AM CC-W186a
Topics in Oncology Clinical Trial Design and Drug Development — Contributed Papers
Biopharmaceutical Section
Chair(s): Elande Baro, FDA
8:35 AM Graphical Testing Procedure in a Hypothetical Seamless Phase II/III Oncology Study Jiacheng Yuan, Bayer HealthCare Pharmaceuticals ; Jonathan Siegel, Bayer HealthCare Pharmaceuticals ; Daniel Haverstock, Bayer HealthCare Pharmaceuticals
8:50 AM The Rapid Enrollment Design for Phase I Clinical Trials Yunfei Wang, Children's National
9:05 AM Paired Survival Endpoints in Crossover Trials Rengyi Xu, University of Pennsylvania ; Devan V. Mehrotra, Merck ; Pamela A. Shaw, University of Pennsylvania
9:20 AM Multiplicity Adjustment Considerations in Designing a Confirmatory Oncology Clinical Trial with Multiple Endpoints Di Li
9:35 AM A New Design for Drug Combination in Phase I Dose-Finding Clinical Trials Jim Xiang, Janssen ; Grace Liu, Johnson & Johnson ; James Pan, Janssen
9:50 AM Benefit-Risk Analysis for Dose-Escalation Trial Hiya Banerjee
10:05 AM Floor Discussion
Copyright © American Statistical Association